Dementia as a rare neurological adverse event of Nivolumab in a patient with metastatic renal cell carcinoma
{{output}}
BackgroundImmune checkpoint inhibitors (ICIs) have transformed cancer therapy but can cause immune-related adverse events (irAEs). Neurological irAEs are rare, and dementia associated with nivolumab has been rarely reported.Case PresentationA 68-year-old femal... ...
